tiprankstipranks
Zomedica (ZOMDF)
OTHER OTC:ZOMDF
US Market
ZOMDF
Zomedica
RESEARCH TOOLSreports
Want to see ZOMDF full AI Analyst Report?

Zomedica (ZOMDF) Earnings Dates, Call Summary & Reports

4,815 Followers

Earnings Data

Report Date
Aug 12, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
―
Last Year’s EPS
-0.01
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2024
Earnings Call Date:Mar 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Zomedica's earnings call highlighted strong revenue growth, especially in the diagnostics segment, and successful international expansion. However, these positives were countered by significant challenges, including the delisting from the NYSE and an increased net loss. The company's strong liquidity position and product innovation are promising, but these are tempered by market and operational challenges.
Company Guidance
During the Zomedica Fourth Quarter 2024 financial results conference call, CEO Larry Heaton highlighted the company's achievements, including record revenues for the quarter at $7.9 million, marking 8% year-over-year growth. This contributed to a full-year revenue of $27.3 million, demonstrating strong performance in both the therapeutic devices and diagnostics segments. Heaton emphasized the success of their products, such as TRUFORMA and VetGuardian, which saw year-over-year growth of 65% and 95%, respectively. Additionally, the company maintained a healthy gross margin of 70.3%, exceeding the target range. Zomedica's liquidity stood strong with over $71 million, and the company reported a net loss of $7.2 million for the quarter. Heaton addressed concerns about the recent delisting from the NYSE American Exchange, explaining the transition to the OTCQB market and affirming the company's commitment to continue driving growth and achieving profitability.
Record Quarterly Revenue
Zomedica achieved a record quarterly revenue of $7.9 million for Q4 2024, reflecting an 8% growth over the prior year quarter.
Significant Growth in Diagnostics Segment
The Diagnostics segment saw a 109% year-over-year increase driven by the growing adoption of TRUFORMA assays and contributions from TRUVIEW and VetGuardian product lines.
International Expansion
Zomedica expanded its global reach by obtaining CE marking for multiple products and signing strategic partnerships with leading distributors in Europe, the Middle East, and other markets, opening up new revenue opportunities.
Launch of New Products
Multiple new products and innovations were launched, including new TRUFORMA assays, the Vetigel Hemostatic Gel, and enhancements to the TRUVIEW platform.
Strong Liquidity Position
The company reported having over $71 million in liquidity with no debt, indicating a strong financial base.

Zomedica (ZOMDF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

ZOMDF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2026 (Q2)
- / -
-0.01―――
May 06, 2026
2026 (Q1)
- / 0.00
-0.07―――
Mar 16, 2026
2025 (Q4)
- / >-0.01
-0.00728.57% (<+0.01)――
Nov 04, 2025
2025 (Q3)
- / -0.01
-0.010.00% (0.00)―
Aug 06, 2025
2025 (Q2)
>-0.01 / -0.01
-0.02458.33% (+0.01)――
May 15, 2025
2025 (Q1)
>-0.01 / -0.07
-0.009-677.78% (-0.06)―
Mar 13, 2025
2024 (Q4)
>-0.01 / >-0.01
-0.02369.57% (+0.02)―
Nov 07, 2024
2024 (Q3)
- / -0.01
-0.001-900.00% (>-0.01)―
Aug 14, 2024
2024 (Q2)
- / -0.02
-0.01-140.00% (-0.01)―
May 09, 2024
2024 (Q1)
- / -
-0.007――
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ZOMDF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$0.09$0.10+11.96%
Mar 16, 2026
$0.13$0.13-0.79%
Nov 04, 2025
$0.08$0.08+6.58%
Aug 06, 2025
$0.04$0.04+8.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zomedica (ZOMDF) report earnings?
Zomedica (ZOMDF) is schdueled to report earning on Aug 12, 2026, TBA (Confirmed).
    What is Zomedica (ZOMDF) earnings time?
    Zomedica (ZOMDF) earnings time is at Aug 12, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ZOMDF EPS forecast?
          Currently, no data Available